Qualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with copaxone

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 1, 2011, Pages 77-82

  Landa, Gennady ^a,b   Rosen, Richard B ^a,b   Patel, Amar ^a   Lima, Veronica Castro ^a,c   Tai, Katy W ^a   Perez, Violete R ^a   Aizman, Alexander ^d   Garcia, Patricia M T ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DRUSEN; HUMAN; IMAGE ANALYSIS; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT RESPONSE; ULTRASTRUCTURE;

HUMANS; INJECTIONS, SUBCUTANEOUS; MACULAR DEGENERATION; PEPTIDES; PROSPECTIVE STUDIES; RETINAL DRUSEN; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 79951985780     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0109     Document Type: Article

References (27)

1. Gass, J.D. Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 90:206-217, 1973.
2. Davis, M.D., Gangnon, R.E., Lee, L.Y., et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch. Ophthalmol. 123:1484-1498, 2005.
3. Ferris, F.L., Davis, M.D., Clemons, T.E., et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch. Ophthalmol. 123:1570-1574, 2005.
4. Klein, R., Klein, B.E., Knudtson, M.D., et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253-262, 2007. (Pubitemid 46161820)
5. Klein, R., Peto, T., Bird, A., and Vannewkirk, M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137:486-495, 2004.
6. Sarks, S.H. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust. J. Ophthalmol. 10:91-97, 1982.
7. Wang, J.J., Foran, S., Smith, W., and Mitchell, P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch. Ophthalmol. 121:658-663, 2003.
8. Sebag, M., Peli, E., and Lahav, M. Image analysis of changes in drusen area. Acta Ophthalmol. (Copenh.) 69:603-610, 1991.
9. Sarks, S.H. Council Lecture. Drusen and their relationship to senile macular degeneration. Aust. J. Ophthalmol. 8:117-130, 1980.
10. Green, W.R., and Enger, C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. 1992. Retina 25(5 Suppl):1519-1535, 2005.
11. Klein, R., Klein, B.E., Tomany, S.C., et al. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 109:1767-1779, 2002.
12. Bressler, N.M., Munoz, B., Maguire, M.G., et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch. Ophthalmol. 113:301-308, 1995.
13. Sparrow, J.M., Dickinson, A.J., Duke, A.M., et al. Seven year follow-up of age-related maculopathy in an elderly British population. Eye 11 (Pt 3):315-324, 1997. (Pubitemid 27344810)
14. Landa, G., Butovsky, O., Shoshani, J., et al. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr. Eye Res. 33:1011-1013, 2008.
15. Yi, K., Mujat, M., Park, B.H., et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br. J. Ophthalmol. 93:176-181, 2009.
16. Chen, Y., Vuong, L.N., Liu, J., et al. Three-dimensional ultrahigh resolution optical coherence tomography imaging of age-related macular degeneration. Opt Express 17:4046-4060, 2009.
17. Coscas, G., Coscas, F., Vismara, S., et al. [Spectral Domain OCT in age-related macular degeneration: preliminary results with Spectralis HRA-OCT]. J. Fr. Ophtalmol. 31:353-361, 2008.
18. Khanifar, A.A., Koreishi, A.F., Izatt, J.A., and Toth, C.A. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 115:1883-1890, 2008.
19. Schuman, S.G., Koreishi, A.F., Farsiu, S., et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology 116:488-496 e2, 2009.
20. Spraul, C.W., Lang, G.E., and Lang, G.K. [Value of optical coherence tomography in diagnosis of age-related macular degeneration. Correlation of fluorescein angiography and OCT findings]. Klin. Monatsbl. Augenheilkd. 212:141-148, 1998.
21. Klein, R., Klein, B.E., and Linton, K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933-943, 1992.
22. Rudolf, M., Clark, M.E., Chimento, M.F., et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 49:1200-1209, 2008.
23. Mullins, R.F., and Hageman, G.S. Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J. Histochem. Cytochem. 47:1533-1540, 1999.
24. Spraul, C.W., Lang, G.E., Grossniklaus, H.E., and Lang, G.K. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv. Ophthalmol. 44(Suppl 1):S10-S32, 1999.
25. Crabb, J.W., Miyagi, M., Gu, X., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 99:14682-14687, 2002.
26. Freeman, S.R., Kozak, I., Cheng, L., et al. Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina 30:431-435, 2010.
27. Parodi, M.B., Virgili, G., and Evans, J.R. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst. Rev. (3):CD006537, 2009.